Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results , with sales up 5.2% year on year to $4.1 billion. The ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

AI is transforming health care, but a new study from researchers at Johns Hopkins, Georgetown, and Yale suggests we might be ...

NeoGenomics reaffirmed its full-year 2025 guidance, projecting revenue between $720 million and $726 million, representing 9-10% growth from fiscal 2024. The company expects a net loss between $108 ...

Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC With ...